MedLife Medical System confirms the acquisition of 50 percent of the shares of the Neolife Romania oncology centers, one of the largest medical players in the Oncology segment in Romania and a household name in Eastern Europe. According to company representatives, the transaction is to be vetted by the Competition Council.
The Neolife Oncology Center Romania, has been operating for seven years in the Romanian market. It operates four medical centers and is a member of the Bozlu Group, Turkey, which owns 21 companies. It has been operating in the field of healthcare and technological services for 32 years. The Neolife brand’s experience in nuclear medicine dates back to 1989 when the first private company providing such services in a hospital was opened in Turkey. Just one year later, in 1990, the first stand-alone private center was opened. Since then, its development has been very fast, and now cancer diagnosis and treatment services are provided in more than 60 public and private hospitals in Turkey.
“Neolife is an innovator in medicine, they introduced revolutionary diagnostic and treatment techniques and equipment in Romania, and the expertise they have in the most advanced European protocols for the treatment of diseases places the company in the top of the field. MedLife always brings together leaders, businesses and people who do their jobs extraordinarily well, and by this partnership with Neolife, we are once again reinforcing our long-term commitment to expanding our offer of excellent medical services benefiting patients all over the country. Furthermore, given the expertise and excellence in Radiotherapy and Nuclear Medicine developed by Neolife in neighbouring countries such as Bulgaria and Moldova in the future we aim to develop partnerships beyond Romania. Moreover, we have found an excellent management team there and we want them to stay with us to strengthen the Oncological Diagnosis and Treatment Services at group level,” said Mihai Marcu.
Neolife brand (managed by MNT Healthcare Europe entered the Romanian market in 2014 when it successfully launched the first oncology center in Bucharest providing diagnostic and treatment services. Neolife Medical Center Bucharest (Baneasa) is mainly equipped with two highly competitive Varian linear accelerators for Radiotherapy and Radiosurgery, a Brachytherapy system, a strong Nuclear Medicine department (PET-CT and Scintigraphy) and a high-performance Chemotherapy section.
In 2016, the 2nd Neolife Oncology Center was opened în Iași, offering the same range of diagnosis and treatment services. Three years later the 3rd center, Neolife Medical Center Brasov, the first nuclear medicine center (PET-CT) in Brasov, was opened. Neolife opened its 4th Oncology Diagnostic and Treatment Center in Summer 2021, also located in Bucharest (Enayati Medical City). In this center, patients have access to PET-CT diagnosis and oncological radiotherapy treatment with Varian’s innovative new and powerful platform, Halcyon 3.0.
The Neolife Medical Center Romania, with a total of 250 employees and partners, closed 2020 with a turnover of 92 million RON, an increase of over 30 percent as compared to 2019.